Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | MAOA | P21397 | 1/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.39 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.39 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13507917 | 0.89 | LIMK1 (0.44) | LIMK1MAOBMAOARXFP1MAPT | |
| SCHEMBL13508145 | 0.88 | LIMK1 (0.48) | LIMK1MAOBMAOARXFP1MAPT | |
| SCHEMBL13507867 | 0.87 | MAOB (0.57) | LIMK1MAOBMAOARXFP1MAPT | |
| SCHEMBL13506802 | 0.84 | MAPK14 (0.40) | MAOBMAOANR3C1MAPK14 | |
| SCHEMBL13564062 | 0.84 | MAOB (0.47) | LIMK1MAOBMAOAKMT2ANR3C1 | |
| SCHEMBL24994009 | 0.83 | RXRA (0.54) | MAOBRXFP1MAPTKDM4EKMT2A | |
| SCHEMBL13508060 | 0.82 | MAOB (0.52) | LIMK1MAOBMAOARXFP1MAPT | |
| SCHEMBL13507629 | 0.80 | LIMK1 (0.47) | LIMK1MAOBMAOARXFP1MAPT | |
| SCHEMBL13507734 | 0.80 | LIMK1 (0.44) | LIMK1MAOBRXFP1MAPTKDM4E | |
| SCHEMBL13507633 | 0.79 | MAOB (0.50) | LIMK1MAOBMAOAKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | GRACEL DISPLAY INC. (KR) | 2010-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100032658-A1 | Novel organic electroluminescent compounds and organic electroluminescent device using the same | OCIAD1, OCIAD2, ORMDL3 | LIMK1 222/4885MAOB 446/4885MAOA 410/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.